Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.
David Gleeson, BM BCH
Advertisement
Dermatology registrar at St John's Institute of Dermatology and NIHR academic clinical fellow and PhD candidate at King's College London.
Articles by David Gleeson, BM BCH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Tilrekimig Meets EASI-75 Goal in Atopic Dermatitis, With Eric Simpson, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Tips on Optimizing HS Biologics, Combinations, and Surgery
4
Why "Normal" Ferritin Can Miss Iron Deficiency, With Jacquelyn Powers, MD, MS
5